Hakan Parlakpınar

34PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesMolecular targetsRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 27, 2026
Cardiovascular Protection with Sulfasalazine During Doxorubicin Challenge: Evidence from Oxidative and Histologic Endpoints.

|Aug 18, 2026
Neuroprotective effects of myricetin against rotenone-ınduced parkinsonian neurotoxicity: a multidimensional analysis in rats.

|Jul 23, 2026
Naringenin protects against renal ischemia-reperfusion injury following unilateral nephrectomy via modulation of oxidative stress and kisspeptin expression.

|May 21, 2026
Nebivolol as a potential adjunct therapy for sepsis-induced cardiac dysfunction: evidence from a rat model.

|May 10, 2026
Evaluation of vinpocetine in an acute doxorubicin-induced cardiotoxicity model in rats.

|Apr 14, 2026
Cytoprotective Effects of Agomelatine on Hepatic Ischemia-Reperfusion Injury in a Rat Model.

Yilmaz Bilgic, Sami Akbulut, Oguzhan Yildirim

Pageof 6

Frequent Collaborators

25 joint publications

Onural Ozhan

16 joint publications

Azibe Yıldız

14 joint publications

Nigar Vardı

9 joint publications

Haci Ahmet Acet